Fig. 1.
Maximum-likelihood phylogeny of all available Norwegian N. gonorrhoeae in the data set based on core genome SNPs. Showing STs (represented by ≥10 isolates), clusters defined by BAPS level 1, and patient data (sex, age, sampling site and residency). Phenotypic susceptible/intermediate/resistant (SIR) data using the EUCAST breakpoints shown for ciprofloxacin (CIP), cefixime (CFM), azithromycin (AZM); penicillin G (PCN), and tetracycline (TET). No isolates were observed resistant to ceftriaxone (CRO) (>0.125 mg l−1) or spectinomycin (SPX) (>64 mg l−1). Grey bars indicate missing data.
